Function of SP1 in tumors and focused treatment approaches for immune evasion (Review)
- Authors:
- Xin Wang
- Pingping Cui
- Yongqi Deng
- Baohua Zhang
- Zhihui Gao
- Tangyue Li
- Yingchun Yin
- Jing Li
-
Affiliations: School of Clinical Medicine, Shandong Second Medical University, Weifang, Shandong 261053, P.R. China, Peking University Health Science Center, Peking University First Hospital, Xicheng, Beijing 100034, P.R. China, Department of Pathology, Zibo Central Hospital, Zibo, Shandong 255020, P.R. China - Published online on: August 14, 2025 https://doi.org/10.3892/ol.2025.15230
- Article Number: 483
-
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Xu Y, Wu W, Han Q, Wang Y, Li C, Zhang P and Xu H: Post-translational modification control of RNA-binding protein hnRNPK function. Open Biol. 9:1802392019. View Article : Google Scholar : PubMed/NCBI | |
|
Huang T, Song X, Xu D, Tiek D, Goenka A, Wu B, Sastry N, Hu B and Cheng SY: Stem cell programs in cancer initiation, progression, and therapy resistance. Theranostics. 10:8721–8743. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu W, Meng J, Su R, Shen C, Zhang S, Zhao Y, Liu W, Du J, Zhu S, Li P, et al: SP1-mediated up-regulation of lncRNA TUG1 underlines an oncogenic property in colorectal cancer. Cell Death Dis. 13:4332022. View Article : Google Scholar : PubMed/NCBI | |
|
Sun X, Xiao C, Wang X, Wu S, Yang Z, Sui B and Song Y: Role of post-translational modifications of Sp1 in cancer: State of the art. Front Cell Dev Biol. 12:14124612024. View Article : Google Scholar : PubMed/NCBI | |
|
Xu XW, Pan CW, Yang XM, Zhou L, Zheng ZQ and Li DC: SP1 reduces autophagic flux through activating p62 in gastric cancer cells. Mol Med Rep. 17:4633–4638. 2018.PubMed/NCBI | |
|
Zhang L, Pan J, Wang M, Yang J, Zhu S, Li L, Hu X, Wang Z, Pang L, Li P, et al: Chronic stress-induced and tumor derived SP1+ exosomes polarizing IL-1β+ neutrophils to increase lung metastasis of breast cancer. Adv Sci (Weinh). 12:e23102662025. View Article : Google Scholar : PubMed/NCBI | |
|
Dynan WS and Tjian R: The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell. 35:79–87. 1983. View Article : Google Scholar : PubMed/NCBI | |
|
Lai YH, Kuo C, Kuo MT and Chen HH: Modulating chemosensitivity of tumors to platinum-based antitumor drugs by transcriptional regulation of copper homeostasis. Int J Mol Sci. 19:14862018. View Article : Google Scholar : PubMed/NCBI | |
|
Crossley M, Whitelaw E, Perkins A, Williams G, Fujiwara Y and Orkin SH: Isolation and characterization of the cDNA encoding BKLF/TEF-2, a major CACCC-box-binding protein in erythroid cells and selected other cells. Mol Cell Biol. 16:1695–1705. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Shields JM and Yang VW: Identification of the DNA sequence that interacts with the gut-enriched Krüppel-like factor. Nucleic Acids Res. 26:796–802. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Samson S and Wong N: Role of Sp1 in insulin regulation of gene expression. J Mol Endocrinol. 29:265–279. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Bouwman P and Philipsen S: Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol. 195:27–38. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Briggs MR, Kadonaga JT, Bell SP and Tjian R: Purification and biochemical characterization of the promoter-specific transcription factor, Sp1. Science. 234:47–52. 1986. View Article : Google Scholar : PubMed/NCBI | |
|
Safe S: Specificity proteins (sp) and cancer. Int J Mol Sci. 24:51642023. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang JF, Zhou ZY, Liu YZ, Wu L, Nie BB, Huang L and Zhang C: Role of Sp1 in atherosclerosis. Mol Biol Rep. 49:9893–9902. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Orzechowska-Licari EJ, LaComb JF, Mojumdar A and Bialkowska AB: SP and KLF transcription factors in cancer metabolism. Int J Mol Sci. 23:99562022. View Article : Google Scholar : PubMed/NCBI | |
|
Hata J, Matsuda K, Ninomiya T, Yonemoto K, Matsushita T, Ohnishi Y, Saito S, Kitazono T, Ibayashi S, Iida M, et al: Functional SNP in an Sp1-binding site of AGTRL1 gene is associated with susceptibility to brain infarction. Hum Mol Genet. 16:630–639. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, Zeng L, Cai L, Zheng W, Liu X, Xiao Y, Jin X, Bai Y, Lai M, Li H, et al: Cellular senescence-associated gene IFI16 promotes HMOX1-dependent evasion of ferroptosis and radioresistance in glioblastoma. Nat Commun. 16:12122025. View Article : Google Scholar : PubMed/NCBI | |
|
Shan L, Wang W, Du L, Li D, Wang Y, Xie Y, Li H, Wang J, Shi Z, Zhou Y, et al: SP1 undergoes phase separation and activates RGS20 expression through super-enhancers to promote lung adenocarcinoma progression. Proc Natl Acad Sci USA. 121:e24018341212024. View Article : Google Scholar : PubMed/NCBI | |
|
Wang X, Jiang A, Meng Q, Jiang T, Lu H, Geng X, Song Z, Hu X, Yu Z, Xu W, et al: Aberrant phase separation drives membranous organelle remodeling and tumorigenesis. Mol Cell. 85:1852–1867. 2025. View Article : Google Scholar : PubMed/NCBI | |
|
Chuang J, Lo W, Ko C, Chou SY, Chen RM, Chang KY, Hung JJ, Su WC, Chang WC and Hsu TI: Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma. Oncogenesis. 6:e339. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lo WL, Hsu TI, Yang WB, Kao TJ, Wu MH, Huang YN, Yeh SH and Chuang JY: Betulinic acid-mediated tuning of PERK/CHOP signaling by Sp1 inhibition as a novel therapeutic strategy for glioblastoma. Cancers (Basel). 12:9812020. View Article : Google Scholar : PubMed/NCBI | |
|
Lan T, Gao F, Cai Y, Lv Y, Zhu J, Liu H, Xie S, Wan H, He H, Xie K, et al: The protein circPETH-147aa regulates metabolic reprogramming in hepatocellular carcinoma cells to remodel immunosuppressive microenvironment. Nat Commun. 16:3332025. View Article : Google Scholar : PubMed/NCBI | |
|
Emili A, Greenblatt J and Ingles CJ: Species-specific interaction of the glutamine-rich activation domains of Spl with the TATA box-binding protein. Mol Cell Biol. 14:1582–1593. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Vellingiri B, Iyer M, Subramaniam MD, Jayaramayya K, Siama Z, Giridharan B, Narayanasamy A, Dayem AA and Cho SG: Understanding the role of the transcription factor Sp1 in ovarian cancer: From theory to practice. Int J Mol Sci. 21:11532020. View Article : Google Scholar : PubMed/NCBI | |
|
Billon N, Carlisi D, Datto MB, van Grunsven LA, Watt A, Wang XF and Rudkin B: Cooperation of Sp1 and p300 in the induction of the CDK inhibitor p21WAF1/CIP1 during NGF-mediated neuronal differentiation. Oncogene. 18:2872–2882. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Pascal E and Tjian R: Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev. 5:1646–1656. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Su W, Jackson S, Tjian R and Echols H: DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1. Genes Dev. 5:820–826. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Eni-Aganga I: Kruppel-Like Factor 6 Promotes Specificity Protein 1-Mediated Prolidase Transcription During Transforming Growth Factor-β1 Signaling. ProQuest LLC; Hamburg: pp. 1–24. 2024 | |
|
Ström AC, Forsberg M, Lillhager P and Westin G: The transcription factors Sp1 and Oct-1 interact physically to regulate human U2 snRNA gene expression. Nucleic Acids Res. 24:1981–1986. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Lim K and Chang HI: O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1. FEBS Lett. 583:512–520. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Porter W, Saville B, Hoivik D and Safe S: Functional synergy between the transcription factor Sp1 and the estrogen receptor. Mol Endocrinol. 11:1569–1580. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Jin Z, Zhou S, Ye H, Jiang S, Yu K and Ma Y: The mechanism of SP1/p300 complex promotes proliferation of multiple myeloma cells through regulating IQGAP1 transcription. Biomed Pharmacother. 119:1094342019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou X, Liu C and Xia D: Sevoflurane-induced P300 promotes neuron apoptosis via Sp1/CDK9 pathway. Clin Exp Pharmacol Physiol. 50:541–553. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Dong L and Gao L: SP1-Driven FOXM1 upregulation induces dopaminergic neuron injury in Parkinson's disease. Mol Neurobiol. 61:5510–5524. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Chen Z, Guan D, Wang Z, Li X, Dong S, Huang J and Zhou W: Microbiota in cancer: Molecular mechanisms and therapeutic interventions. MedComm (2020). 4:e4172023. View Article : Google Scholar : PubMed/NCBI | |
|
Young MJ, Chen YC, Wang SA, Chang HP, Yang WB, Lee CC, Liu CY, Tseng YL, Wang YC, Sun HS, et al: Estradiol-mediated inhibition of Sp1 decreases miR-3194-5p expression to enhance CD44 expression during lung cancer progression. J Biomed Sci. 29:32022. View Article : Google Scholar : PubMed/NCBI | |
|
Jungert K, Buck A, von Wichert G, Adler G, König A, Buchholz M, Gress TM and Ellenrieder V: Sp1 is required for transforming growth factor-β-induced mesenchymal transition and migration in pancreatic cancer cells. Cancer Res. 67:1563–1570. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Ashaie MA and Chowdhury EH: Cadherins: The superfamily critically involved in breast cancer. Curr Pharm Des. 22:616–638. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ripple MJ, Struckhoff AP, Trillo-Tinoco J, Li L, Margolin DA, McGoey R and Del Valle L: Activation of c-Myc and cyclin D1 by JCV T-antigen and β-catenin in colon cancer. PLoS One. 9:e1062572014. View Article : Google Scholar : PubMed/NCBI | |
|
Fang Y, Tang W, Qu S, Li Z, Zhang X, Miao Y, Zeng Z and Huang H: RBBP7, regulated by SP1, enhances the Warburg effect to facilitate the proliferation of hepatocellular carcinoma cells via PI3K/AKT signaling. J Transl Med. 22:1702024. View Article : Google Scholar : PubMed/NCBI | |
|
Qiu W, Guo Q, Guo X, Wang C, Li B, Qi Y, Wang S, Zhao R, Han X, Du H, et al: Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21/SP1/DNMT1 positive feedback loop. J Nanobiotechnology. 21:2332023. View Article : Google Scholar : PubMed/NCBI | |
|
Hu Z, You L, Hu S, Yu L, Gao Y, Li L and Zhang S: Hepatocellular carcinoma cell-derived exosomal miR-21-5p promotes the polarization of tumor-related macrophages (TAMs) through SP1/XBP1 and affects the progression of hepatocellular carcinoma. Int Immunopharmacol. 126:1111492024. View Article : Google Scholar : PubMed/NCBI | |
|
Tian X, Wang T, Shen H and Wang S: Tumor microenvironment, histone modifications, and myeloid-derived suppressor cells. Cytokine Growth Factor Rev. 74:108–121. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Su X, Liang C, Chen R and Duan S: Deciphering tumor microenvironment: CXCL9 and SPP1 as crucial determinants of tumor-associated macrophage polarity and prognostic indicators. Mol Cancer. 23:132024. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Xun Z, Ma K, Liang S, Li X, Zhou S, Sun L, Liu Y, Du Y, Guo X, et al: Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy. J Hepatol. 78:770–782. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Shentu J, Su X, Yu Y and Duan S: Unveiling the role of taurine and SLC6A6 in tumor immune evasion: Implications for gastric cancer therapy. Int J Biochem Cell Biol. 176:1066612024. View Article : Google Scholar : PubMed/NCBI | |
|
Oleksiewicz U, Kuciak M, Jaworska A, Adamczak D, Bisok A, Mierzejewska J, Sadowska J, Czerwinska P and Mackiewicz AA: The roles of H3K9me3 writers, readers, and erasers in cancer immunotherapy. Int J Mol Sci. 25:114662024. View Article : Google Scholar : PubMed/NCBI | |
|
Pan J, Li Y, Gao W, Jiang Q, Geng L, Ding J, Li S and Li J: Transcription factor Sp1 transcriptionally enhances GSDME expression for pyroptosis. Cell Death Dis. 15:662024. View Article : Google Scholar : PubMed/NCBI | |
|
Huang MD, Chen WM, Qi FZ, Sun M, Xu TP, Ma P and Shu YQ: Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2. Mol Cancer. 14:1–12. 2015. View Article : Google Scholar | |
|
Zhang W, Yang H, Wang Z, Wu Y, Wang J, Duan G, Guo Q and Zhang Y: miR-320a/SP1 negative reciprocal interaction contributes to cell growth and invasion in colorectal cancer. Cancer Cell Int. 21:1–13. 2021.PubMed/NCBI | |
|
Li J, Peng W, Yang P, Chen R, Gu Q, Qian W, Ji D, Wang Q, Zhang Z, Tang J and Sun Y: MicroRNA-1224-5p inhibits metastasis and epithelial-mesenchymal transition in colorectal cancer by targeting SP1-mediated NF-κB signaling pathways. Front Oncol. 10:2942020. View Article : Google Scholar : PubMed/NCBI | |
|
Xu W, Lou W and Mei L: A key regulatory loop AK4P1/miR-375/SP1 in pancreatic adenocarcinoma. Epigenetics. 18:21484332023. View Article : Google Scholar : PubMed/NCBI | |
|
Yu S, Wang D, Shao Y, Zhang T, Xie H, Jiang X, Deng Q, Jiao Y, Yang J, Cai C and Sun L: SP1-induced lncRNA TINCR overexpression contributes to colorectal cancer progression by sponging miR-7-5p. Aging (Albany NY). 11:1389–1403. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Zeng K, Xu M, Hu X, Liu X, Xu T, He B, Pan Y, Sun H and Wang S: SP1-induced lncRNA-ZFAS1 contributes to colorectal cancer progression via the miR-150-5p/VEGFA axis. Cell Death Dis. 9:9822018. View Article : Google Scholar : PubMed/NCBI | |
|
Sun W, Wang X, Li J, You C, Lu P, Feng H, Kong Y, Zhang H, Liu Y, Jiao R, et al: MicroRNA-181a promotes angiogenesis in colorectal cancer by targeting SRCIN1 to promote the SRC/VEGF signaling pathway. Cell Death Dis. 9:4382018. View Article : Google Scholar : PubMed/NCBI | |
|
Wu S, Meng Q, Zhang C, Sun H, Lu R, Gao N, Yang H, Li X, Aschner M and Chen R: DR4 mediates the progression, invasion, metastasis and survival of colorectal cancer through the Sp1/NF1 switch axis on genomic locus. Int J Cancer. 143:289–297. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Yao J, Shi H, Gao B, Zhou H, Zhang Y, Zhao D, Gao S, Wang C and Zhang L: Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt/β-catenin pathway. Cell Death Dis. 12:8022021. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Y, Peng K, Li H, Zhuang R, Wang Y, Li W, Yu S, Liang L, Xu X and Liu T: SP1 upregulated FoxO3a promotes tumor progression in colorectal cancer. Oncol Rep. 39:2235–2242. 2018.PubMed/NCBI | |
|
Shi S and Zhang ZG: Role of Sp1 expression in gastric cancer: A meta-analysis and bioinformatics analysis. Oncol Lett. 18:4126–4135. 2019.PubMed/NCBI | |
|
Chen JJ, Ren YL, Shu CJ, Zhang Y, Chen MJ, Xu J, Li J, Li AP, Chen DY, He JD, et al: JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis. J Exp Clin Cancer Res. 39:1–14. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Guo Y, Zhuang T, Xu T and Ji M: SP1-induced upregulation of lncRNA LINC00659 promotes tumour progression in gastric cancer by regulating miR-370/AQP3 axis. Front Endocrinol (Lausanne). 13:9360372022. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Yang H, Jia Y, Xu Z, Zhang L, Sun M and Fu J: circRNA_0005529 facilitates growth and metastasis of gastric cancer via regulating miR-527/Sp1 axis. BMC Mol Cell Biol. 22:1–15. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Z, Li Z, Wang C, Pan T, Chang X, Wang X, Zhou Q, Wu X, Li J, Zhang J, et al: Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M. Gastric Cancer. 22:955–966. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Yang K, Li J, Zhu J, Chen Y, He Y, Wang J, Shen K, Wang K, Shi T and Chen W: HOOK3 suppresses proliferation and metastasis in gastric cancer via the SP1/VEGFA axis. Cell Death Discov. 10:332024. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Du Y, Hu X, Zhao L and Xia W: Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer. BMC Cancer. 18:1–11. 2018. | |
|
Monteleone E, Orecchia V, Corrieri P, Schiavone D, Avalle L, Moiso E, Savino A, Molineris I, Provero P and Poli V: SP1 and STAT3 functionally synergize to induce the RhoU small GTPase and a subclass of non-canonical WNT responsive genes correlating with poor prognosis in breast cancer. Cancers (Basel). 11:1012019. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Zou ZZ, Wen M, Xie YZ, Peng KJ, Luo T, Liu SY, Gu Q, Li JJ and Luo ZY: ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis. Mol Med. 26:1092020. View Article : Google Scholar : PubMed/NCBI | |
|
Li G, Xie Q, Yang Z, Wang L, Zhang X, Zuo B, Zhang S, Yang A and Jia L: Sp1-mediated epigenetic dysregulation dictates HDAC inhibitor susceptibility of HER2-overexpressing breast cancer. Int J Cancer. 145:3285–3298. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Cai F, Chen L, Sun Y, He C, Fu D and Tang J: MiR-539 inhibits the malignant behavior of breast cancer cells by targeting SP1. Biochem Cell Biol. 98:426–433. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang S, Huang P, Dai H, Li Q, Hu L, Peng J, Jiang S, Xu Y, Wu Z, Nie H, et al: TIMELESS regulates sphingolipid metabolism and tumor cell growth through Sp1/ACER2/S1P axis in ER-positive breast cancer. Cell Death Dis. 11:8922020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang X, Li F, Zhou Y, Mao F, Lin Y, Shen S, Li Y, Zhang S and Sun Q: Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer. Cell Death Dis. 12:6272021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang XX, Guo GC, Qian XK, Dou DW, Zhang Z, Xu XD, Duan X and Pei XH: miR-506 attenuates methylation of lncRNA MEG3 to inhibit migration and invasion of breast cancer cell lines via targeting SP1 and SP3. Cancer Cell Int. 18:1712018. View Article : Google Scholar : PubMed/NCBI | |
|
Shao W, Li Y, Chen F, Jia H, Jia J and Fu Y: Long non-coding RNA DLEU1 contributes to the development of endometrial cancer by sponging miR-490 to regulate SP1 expression. Pharmazie. 73:379–385. 2018.PubMed/NCBI | |
|
Bai Z, Wu Y, Bai S, Yan Y, Kang H, Ma W, Zhang J, Gao Y, Hui B, Ma H, et al: Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer. J Cell Mol Med. 24:7479–7489. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Cui JW, Li Y, Yang Y, Yang HK, Dong JM, Xiao ZH, He X, Guo JH, Wang RQ, Dai B and Zhou ZL: Tumor immunotherapy resistance: Revealing the mechanism of PD-1/PD-L1-mediated tumor immune escape. Biomed Pharmacother. 171:1162032024. View Article : Google Scholar : PubMed/NCBI | |
|
Kong L, Xu F, Yao Y, Gao Z, Tian P, Zhuang S, Wu D, Li T, Cai Y and Li J: Ascites-derived CDCP1+ extracellular vesicles subcluster as a novel biomarker and therapeutic target for ovarian cancer. Front Oncol. 13:11427552023. View Article : Google Scholar : PubMed/NCBI | |
|
Wang S, Li X, Li J, Wang A, Li F, Hu H, Long T, Pei X, Li H, Zhong F and Zhu F: Inhibition of cisplatin-induced Acsl4-mediated ferroptosis alleviated ovarian injury. Chem Biol Interact. 387:1108252024. View Article : Google Scholar : PubMed/NCBI | |
|
Shen HT, Chien PJ, Chen SH, Sheu GT, Jan MS, Wang BY and Chang W: BMI1-mediated pemetrexed resistance in non-small cell lung cancer cells is associated with increased SP1 activation and cancer stemness. Cancers (Basel). 12:20692020. View Article : Google Scholar : PubMed/NCBI | |
|
Hu L, Chen Q, Wang Y, Zhang N, Meng P, Liu T and Bu Y: Sp1 mediates the constitutive expression and repression of the PDSS2 gene in lung cancer cells. Genes (Basel). 10:9772019. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Fu Y, Xia X, Zhang X, Xiao K, Zhuang X and Zhang Y: Knockdown of SP1/Syncytin1 axis inhibits the proliferation and metastasis through the AKT and ERK1/2 signaling pathways in non-small cell lung cancer. Cancer Med. 8:5750–5759. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Y, Xu K, He M, Fan G and Lu H: Overexpression of glypican 5 (GPC5) inhibits prostate cancer cell proliferation and invasion via suppressing Sp1-mediated EMT and activation of Wnt/β-catenin signaling. Oncol Res. 26:5652018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang ZY, Duan Y and Wang P: SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5. J Cell Physiol. 235:3916–3927. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Liu SK, Song L and Yao HR: SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a. Artif Cells Nanomed Biotechnol. 47:555–563. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Deng YR, Chen XJ, Chen W, Wu LF, Jiang HP, Lin D, Wang LJ, Wang W and Guo SQ: Sp1 contributes to radioresistance of cervical cancer through targeting G2/M cell cycle checkpoint CDK1. Cancer Manag Res. 11:5835–5844. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lin CL, Ying TH, Yang SF, Lin CL, Chiou HL and Hsieh YH: Magnolin targeting of the JNK/Sp1/MMP15 signaling axis suppresses cervical cancer microenvironment and metastasis via microbiota modulation. Cancer Lett. 583:2165842024. View Article : Google Scholar : PubMed/NCBI | |
|
Wang P, Song Y, Li H, Zhuang J, Shen X, Yang W, Mi R, Lu Y, Yang B, Ma M and Shen H: SIRPA enhances osteosarcoma metastasis by stabilizing SP1 and promoting SLC7A3-mediated arginine uptake. Cancer Lett. 576:2164122023. View Article : Google Scholar : PubMed/NCBI | |
|
Wang W and Wang B: KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development. BMC Cancer. 22:5622022. View Article : Google Scholar : PubMed/NCBI | |
|
Mi LD, Sun CX, He SW and Du GY: SP1-induced upregulation of lncRNA LINC00514 promotes tumor proliferation and metastasis in osteosarcoma by regulating miR-708. Cancer Manag Res. 3311–3322. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Hu XH, Dai J, Shang HL, Zhao ZX and Hao YD: SP1-mediated upregulation of lncRNA ILF3-AS1 functions a ceRNA for miR-212 to contribute to osteosarcoma progression via modulation of SOX5. Biochem Biophys Res Commun. 511:510–517. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Moreira J, Almeida J, Saraiva L, Cidade H and Pinto M: Chalcones as promising antitumor agents by targeting the p53 pathway: An overview and new insights in drug-likeness. Molecules. 26:37372021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang B, Song L, Cai J, Li L, Xu H, Li M, Wang J, Shi M, Chen H, Jia H and Hou Z: The LIM protein Ajuba/SP1 complex forms a feed forward loop to induce SP1 target genes and promote pancreatic cancer cell proliferation. J Exp Clin Cancer Res. 8:1–11. 2019. | |
|
Malsy M, Graf B, Bruendl E, Maier-Stocker C and Bundscherer A: Effect of NFATc2-and Sp1-mediated TNFalpha regulation on the proliferation and migration behavior of pancreatic cancer cells. Cancer Genomics Proteomics. 20:706–711. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Cai LJ, Tu L, Li T, Yang XL, Ren YP, Gu R, Zhang Q, Yao H, Qu X, Wang Q and Tian JY: Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease by inhibiting SP1. Aging (Albany NY). 12:672–689. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Dong X, Wu L, Gong L, Huang D, Guo J, Ma M, Xiao L, Xu S, Chang J, Che X and Hang J: PPP3CB inhibits pancreatic cancer progression by promoting ATOH8 translocation and transcriptionally regulating Sp1. Life Sci. 12:36312025. | |
|
Yang J, Wang J, Zhang H, Li C, Chen C and Zhu T: Transcription factor Sp1 is upregulated by PKCι to drive the expression of YAP1 during pancreatic carcinogenesis. Carcinogenesis. 42:344–356. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Gao Y, Zhou Y, Wang C, Sample KM, Yu X and Ben-David Y: Propofol mediates pancreatic cancer cell activity through the repression of ADAM8 via SP1. Oncol Rep. 46:2492021. View Article : Google Scholar : PubMed/NCBI | |
|
Shi X, Wang X and Hua Y: LncRNA GACAT1 promotes gastric cancer cell growth, invasion and migration by regulating MiR-149-mediated of ZBTB2 and SP1. J Cancer. 9:3715–3722. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, Chen P, Fei H, Li M, Li X and Li T: Natural killer cells contributed to recurrent miscarriage by SP1-CASP3-PARP1. Int Immunopharmacol. 93:1074242021. View Article : Google Scholar : PubMed/NCBI | |
|
Bernacchioni C, Capezzuoli T, Vannuzzi V, Malentacchi F, Castiglione F, Cencetti F, Ceccaroni M, Donati C, Bruni P and Petraglia F: Sphingosine 1-phosphate receptors are dysregulated in endometriosis: Possible implication in transforming growth factor β-induced fibrosis. Fertil Steril. 115:501–511. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Lin M, Xu H and Qiu J: Inflammation in recurrent miscarriage-a comprehensive perspective from uterine microenvironment and immune cell imbalance to therapeutic strategies. Ginekol Pol. 95:266–275. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Shen L, Hong X, Liu Y, Zhou W and Zhang Y: The miR-25-3p/Sp1 pathway is dysregulated in ovarian endometriosis. J Int Med Res. Apr 17–2020.(Epub ahead of print). View Article : Google Scholar | |
|
Chen Z: The role of specificity protein 1 (SP1) in bladder cancer progression through PTEN-mediated AKT/mTOR pathway. Urol Int. 107:848–856. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu J, Lu Z, Ke M and Cai X: Sp1 is overexpressed and associated with progression and poor prognosis in bladder urothelial carcinoma patients. Int Urol Nephrol. 54:1505–1512. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Yan H, Li J, Ying Y, Xie H, Chen H, Xu X and Zheng X: MIR-300 in the imprinted DLK1-DIO3 domain suppresses the migration of bladder cancer by regulating the SP1/MMP9 pathway. Cell Cycle. 17:2790–2801. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Fernández-Guizán A, Mansilla S, Barceló F, Vizcaíno C, Núñez LE, Morís F, González S and Portugal J: The activity of a novel mithramycin analog is related to its binding to DNA, cellular accumulation, and inhibition of Sp1-driven gene transcription. Chem Biol Interact. 219:123–132. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ke X, Fei F, Chen Y, Xu L, Zhang Z, Huang Q, Zhang H, Yang H, Chen Z and Xing J: Hypoxia upregulates CD147 through a combined effect of HIF-1α and Sp1 to promote glycolysis and tumor progression in epithelial solid tumors. Carcinogenesis. 33:1598–1607. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Chu PC, Lin PC, Wu HY, Lin KT, Wu C, Bekaii-Saab T, Lin YJ, Lee CT, Lee JC and Chen CS: Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway. Oncogene. 37:3440–3455. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Liu H, Shi Y and Qian F: Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts. Adv Drug Deliv Rev. 172:37–51. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yoon BK, Hwang N, Chun KH, Lee Y, Duarte TPM and Kim JW, Kim TH, Cheong JH, Fang S and Kim JW: Sp1-induced FNBP1 drives rigorous 3D cell motility in EMT-type gastric cancer cells. Int J Mol Sci. 22:67842021. View Article : Google Scholar : PubMed/NCBI | |
|
Shishodia S: Molecular mechanisms of curcumin action: gene expression. Biofactors. 39:37–55. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Nangia V, Siddiqui FM, Caenepeel S, Timonina D, Bilton SJ, Phan N, Gomez-Caraballo M, Archibald HL, Li C, Fraser C, et al: Exploiting MCL1 dependency with combination MEK+ MCL1 inhibitors leads to induction of apoptosis and tumor regression in KRAS-mutant non-small cell lung cancer. Cancer Discov. 8:1598–1613. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Moon Hr, Du Y, Choi SR, et al: DNA origami-cyanine nanocomplex for precision imaging of KRAS-mutant pancreatic cancer cells. Advanced Science. 24102782025. View Article : Google Scholar : PubMed/NCBI | |
|
Hu L and Chen L, Xiao Z, Zheng X, Chen Y, Xian N, Cho C, Luo L, Huang G and Chen L: Ablation of T cell-associated PD-1H enhances functionality and promotes adoptive immunotherapy. JCI insight. 7:e1482472022. View Article : Google Scholar : PubMed/NCBI | |
|
Ryu H, Lee J, Olofsson BA, Mwidau A, Dedeoglu A, Escudero M, Flemington E, Azizkhan-Clifford J, Ferrante RJ and Ratan RR: Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway. Proc Natl Acad Sci USA. 100:4281–4286. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Zang X, He XY, Xiao CM, Lin Q, Wang MY, Liu CY, Kong LY, Chen Z and Xia YZ: Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1. Mol Cancer. 23:2072024. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang N, Zhao SS, Zhang YX, Wang YC, Shao RG, Wang JX and He HW: A novel biphenyl compound IMB-S7 ameliorates hepatic fibrosis in BDL rats by suppressing Sp1-mediated integrin αv expression. Acta Pharmacol Sin. 41:661–669. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y, He M, Ke X, Chen Y, Zhu J, Tan Z and Chen J: Centrosome amplification-related signature correlated with immune microenvironment and treatment response predicts prognosis and improves diagnosis of hepatocellular carcinoma by integrating machine learning and single-cell analyses. Hepatol Int. 18:108–130. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Lu H, Yuan P, Ma X, Jiang X, Liu S, Ma C, Philipsen S, Zhang Q, Yang J, Xu F, et al: Angiotensin-converting enzyme inhibitor promotes angiogenesis through Sp1/Sp3-mediated inhibition of notch signaling in male mice. Nat Commun. 14:7312023. View Article : Google Scholar : PubMed/NCBI | |
|
Gao Y, Gan K, Liu K, Xu B and Chen M: SP1 expression and the clinicopathological features of tumors: A meta-analysis and bioinformatics analysis. Pathol Oncol Res. 27:5819982021. View Article : Google Scholar : PubMed/NCBI | |
|
Blume S, Snyder R, Ray R, Thomas S, Koller C and Miller D: Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest. 88:1613–1621. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Ran XH, Zhu JW, Ni RZ, Zheng YT, Chen YY, Zheng WH and Mu D: TRIM5α recruits HDAC1 to p50 and Sp1 and promotes H3K9 deacetylation at the HIV-1 LTR. Nat Commun. 14:33432023. View Article : Google Scholar : PubMed/NCBI | |
|
Dopler A, Alkan F, Malka Y, van der Kammen R, Hoefakker K, Taranto D, Kocabay N, Mimpen I, Ramirez C, Malzer E, et al: P-stalk ribosomes act as master regulators of cytokine-mediated processes. Cell. 187:6981–6993. 2024. View Article : Google Scholar : PubMed/NCBI | |
|
Wang JS, Zeng QF, Feng DY, Hu YB and Wen JF: Expression and role of nuclear transcription factor Sp1 in macrophages stimulated by silicon dioxide. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 24:518–522. 2006.(In Chinese). PubMed/NCBI | |
|
Yuan X, Li D, Chen X, Han C, Xu L, Huang T, Dong Z and Zhang M: Extracellular vesicles from human-induced pluripotent stem cell-derived mesenchymal stromal cells (hiPSC-MSCs) protect against renal ischemia/reperfusion injury via delivering specificity protein (SP1) and transcriptional activating of sphingosine kinase 1 and inhibiting necroptosis. Cell Death Dis. 8:32002017. View Article : Google Scholar : PubMed/NCBI | |
|
Gao Y, Zhao J, Huang Z, Zhao H, Guo Z, Ma S, Tang X, Song W and Chen X: In Situ Reprogramming of tumors for activating the OX40/OX40 ligand checkpoint pathway and boosting antitumor immunity. ACS Biomater Sci Eng. 9:4108–4116. 2023. View Article : Google Scholar : PubMed/NCBI | |
|
Ye JC and Heng HH: The new era of cancer cytogenetics and cytogenomics. Methods Mol Biol. 2825:3–37. 2024. View Article : Google Scholar : PubMed/NCBI |
